No Data
No Data
No Data
No Data
No Data
Express News | Citius Pharmaceuticals Announces $15 Million Registered Direct Offering
ReutersApr 26 08:00 ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersBio-Path Hldgs (NASDAQ:BPTH) shares increased by 43.8% to $4.66 during Thursday's pre-market session. The market value of their outstanding shares is at $3.5 million. SINTX Techs (NASDAQ:SINT)
BenzingaApr 18 08:09 ET
Express News | University Of Minnesota Masonic Cancer Center Intends To Expand Cirtrus Pharmaceuticals' Ongoing Investigator-Initiated Phase 1 Trial Of LYMPHIR In Combination With FDA-Approved CAR-T Products For B-cell Lymphomas
Moomoo 24/7Apr 11 08:40 ET
Express News | Citius Pharmaceuticals Announces Addition of City of Hope to Umn's Phase 1 Trial of Lymphir in Combination With CAR-T for the Treatment of B-Cell Lymphoma
Moomoo 24/7Apr 11 08:30 ET
Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and...
PR NewswireApr 4 08:30 ET
Positive Outlook for Citius Pharmaceuticals With Lymphir's FDA Resubmission and Market Potential
TipRanksMar 20 13:25 ET
No Data
No Data
买跌不追涨 : 这种不好的消息没必要看了吧
TrytosaveabitOP 买跌不追涨: I put it out so people know why the just lost so much at one shot!
PYUN970IHaveChosen TrytosaveabitOP: Appreciated!
买跌不追涨 TrytosaveabitOP: 好吧,你想帮助尽可能多的人
TrytosaveabitOP PYUN970IHaveChosen: You’re very welcome! GL
View more comments...